CIBC Asset Management Inc Acquires 154 Shares of Encompass Health Co. (NYSE:EHC)

CIBC Asset Management Inc raised its holdings in Encompass Health Co. (NYSE:EHC) by 5.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,111 shares of the company’s stock after buying an additional 154 shares during the period. CIBC Asset Management Inc’s holdings in Encompass Health were worth $287,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in EHC. MassMutual Private Wealth & Trust FSB increased its holdings in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after acquiring an additional 137 shares during the last quarter. Avior Wealth Management LLC bought a new position in Encompass Health during the third quarter worth $40,000. Tompkins Financial Corp acquired a new position in shares of Encompass Health in the fourth quarter valued at $46,000. V Square Quantitative Management LLC raised its position in shares of Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock valued at $54,000 after purchasing an additional 177 shares during the period. Finally, Morse Asset Management Inc acquired a new stake in shares of Encompass Health during the 3rd quarter worth about $68,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

EHC has been the topic of several research analyst reports. KeyCorp increased their price target on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Monday, February 10th. Barclays increased their target price on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. Royal Bank of Canada restated an “outperform” rating and issued a $110.00 price target on shares of Encompass Health in a research note on Tuesday, February 11th. Truist Financial reiterated a “buy” rating and set a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Finally, William Blair reissued an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Ten investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $107.67.

Encompass Health Trading Up 1.4 %

Shares of Encompass Health stock opened at $98.86 on Tuesday. The firm’s 50-day moving average price is $96.01 and its two-hundred day moving average price is $96.05. The company has a market capitalization of $9.96 billion, a price-to-earnings ratio of 22.17, a PEG ratio of 2.31 and a beta of 0.90. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 12-month low of $73.68 and a 12-month high of $104.55.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 17th. Investors of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.69%. The ex-dividend date is Tuesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is presently 15.25%.

Insider Buying and Selling at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the transaction, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 2.10% of the company’s stock.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.